Literature DB >> 27671335

ECM Composition and Rheology Regulate Growth, Motility, and Response to Photodynamic Therapy in 3D Models of Pancreatic Ductal Adenocarcinoma.

Gwendolyn M Cramer1,2, Dustin P Jones1,3, Hamid El-Hamidi1, Jonathan P Celli4.   

Abstract

Pancreatic ductal adenocarcinoma is characterized by prominent stromal involvement, which plays complex roles in regulating tumor growth and therapeutic response. The extracellular matrix (ECM)-rich stroma associated with this disease has been implicated as a barrier to drug penetration, although stromal depletion strategies have had mixed clinical success. It remains less clear how interactions with ECM, acting as a biophysical regulator of phenotype, not only a barrier to drug perfusion, regulate susceptibilities and resistance to specific therapies. In this context, an integrative approach is used to evaluate invasive behavior and motility in rheologically characterized ECM as determinants of chemotherapy and photodynamic therapy (PDT) responses. We show that in 3D cultures with ECM conditions that promote invasive progression, response to PDT is markedly enhanced in the most motile ECM-infiltrating populations, whereas the same cells exhibit chemoresistance. Conversely, drug-resistant sublines with enhanced invasive potential were generated to compare differential treatment response in identical ECM conditions, monitored by particle tracking microrheology measurements of matrix remodeling. In both scenarios, ECM-infiltrating cell populations exhibit increased sensitivity to PDT, whether invasion is consequent to selection of chemoresistance, or whether chemoresistance is correlated with acquisition of invasive behavior. However, while ECM-invading, chemoresistant cells exhibit mesenchymal phenotype, induction of EMT in monolayers without ECM was not sufficient to enhance PDT sensitivity, yet does impart chemoresistance as expected. In addition to containing platform development with broader applicability to inform microenvironment-dependent therapeutics, these results reveal the efficacy of PDT for targeting the most aggressive, chemoresistant, invasive pancreatic ductal adenocarcinoma associated with dismal outcomes for this disease. IMPLICATIONS: ECM-infiltrating and chemoresistant pancreatic tumor populations exhibit increased sensitivity to PDT. Mol Cancer Res; 15(1); 15-25. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2016        PMID: 27671335      PMCID: PMC5381935          DOI: 10.1158/1541-7786.MCR-16-0260

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  48 in total

1.  Type I collagen promotes the malignant phenotype of pancreatic ductal adenocarcinoma.

Authors:  Thomas Armstrong; Graham Packham; Lindsay B Murphy; Adrian C Bateman; John A Conti; David R Fine; Colin D Johnson; R Christopher Benyon; John P Iredale
Journal:  Clin Cancer Res       Date:  2004-11-01       Impact factor: 12.531

Review 2.  Tumor-stroma interactions in pancreatic ductal adenocarcinoma.

Authors:  Daruka Mahadevan; Daniel D Von Hoff
Journal:  Mol Cancer Ther       Date:  2007-04-03       Impact factor: 6.261

3.  Cancer associated fibroblasts: the dark side of the coin.

Authors:  Paolo Cirri; Paola Chiarugi
Journal:  Am J Cancer Res       Date:  2011-03-12       Impact factor: 6.166

4.  Survival in population-based pancreatic cancer patients: San Francisco Bay area, 1995-1999.

Authors:  Zhihong Gong; Elizabeth A Holly; Paige M Bracci
Journal:  Am J Epidemiol       Date:  2011-11-01       Impact factor: 4.897

5.  In vitro invasion assay using matrigel™: a reconstituted basement membrane preparation.

Authors:  Debbie M S Hall; Susan A Brooks
Journal:  Methods Mol Biol       Date:  2014

6.  Pancreatic cancer stroma: friend or foe?

Authors:  Jesse Gore; Murray Korc
Journal:  Cancer Cell       Date:  2014-06-16       Impact factor: 31.743

7.  Distribution of extracellular matrix proteins in pancreatic ductal adenocarcinoma and its influence on tumor cell proliferation in vitro.

Authors:  J Mollenhauer; I Roether; H F Kern
Journal:  Pancreas       Date:  1987       Impact factor: 3.327

8.  Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.

Authors:  Gayathri Subramanian; Roderich E Schwarz; Linda Higgins; Glenn McEnroe; Sarvajit Chakravarty; Sundeep Dugar; Michael Reiss
Journal:  Cancer Res       Date:  2004-08-01       Impact factor: 12.701

9.  Tumor-promoting inflammatory networks in pancreatic neoplasia: another reason to loathe Kras.

Authors:  Robert H Vonderheide
Journal:  Cancer Cell       Date:  2014-05-12       Impact factor: 31.743

10.  An imaging-based platform for high-content, quantitative evaluation of therapeutic response in 3D tumour models.

Authors:  Jonathan P Celli; Imran Rizvi; Adam R Blanden; Iqbal Massodi; Michael D Glidden; Brian W Pogue; Tayyaba Hasan
Journal:  Sci Rep       Date:  2014-01-17       Impact factor: 4.379

View more
  14 in total

1.  Matrix stiffness and tumor-associated macrophages modulate epithelial to mesenchymal transition of human adenocarcinoma cells.

Authors:  Marta Alonso-Nocelo; Theresa M Raimondo; Kyle H Vining; Rafael López-López; Maria de la Fuente; David J Mooney
Journal:  Biofabrication       Date:  2018-03-28       Impact factor: 9.954

2.  Modeling Epidermal Growth Factor Inhibitor-mediated Enhancement of Photodynamic Therapy Efficacy Using 3D Mesothelioma Cell Culture.

Authors:  Gwendolyn Cramer; Michael Shin; Sarah Hagan; Sharyn I Katz; Charles B Simone; Theresa M Busch; Keith A Cengel
Journal:  Photochem Photobiol       Date:  2019-01-07       Impact factor: 3.421

Review 3.  Passive and Active Microrheology for Biomedical Systems.

Authors:  Yating Mao; Paige Nielsen; Jamel Ali
Journal:  Front Bioeng Biotechnol       Date:  2022-07-05

4.  Modulation of Extracellular Matrix Rigidity Via Riboflavin-mediated Photocrosslinking Regulates Invasive Motility and Treatment Response in a 3D Pancreatic Tumor Model.

Authors:  Rojin Jafari; Gwendolyn M Cramer; Jonathan P Celli
Journal:  Photochem Photobiol       Date:  2020-01-07       Impact factor: 3.421

Review 5.  Photodynamic Therapy and the Biophysics of the Tumor Microenvironment.

Authors:  Aaron J Sorrin; Mustafa Kemal Ruhi; Nathaniel A Ferlic; Vida Karimnia; William J Polacheck; Jonathan P Celli; Huang-Chiao Huang; Imran Rizvi
Journal:  Photochem Photobiol       Date:  2020-03-05       Impact factor: 3.421

Review 6.  The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer.

Authors:  Dimakatso Alice Senthebane; Arielle Rowe; Nicholas Ekow Thomford; Hendrina Shipanga; Daniella Munro; Mohammad A M Al Mazeedi; Hashim A M Almazyadi; Karlien Kallmeyer; Collet Dandara; Michael S Pepper; M Iqbal Parker; Kevin Dzobo
Journal:  Int J Mol Sci       Date:  2017-07-21       Impact factor: 5.923

7.  Neoadjuvant photodynamic therapy augments immediate and prolonged oxaliplatin efficacy in metastatic pancreatic cancer organoids.

Authors:  Mans Broekgaarden; Imran Rizvi; Anne-Laure Bulin; Ljubica Petrovic; Ruth Goldschmidt; Iqbal Massodi; Jonathan P Celli; Tayyaba Hasan
Journal:  Oncotarget       Date:  2018-02-06

Review 8.  Chemoresistance of Cancer Cells: Requirements of Tumor Microenvironment-mimicking In Vitro Models in Anti-Cancer Drug Development.

Authors:  Yeonho Jo; Nakwon Choi; Kyobum Kim; Hyung-Jun Koo; Jonghoon Choi; Hong Nam Kim
Journal:  Theranostics       Date:  2018-10-22       Impact factor: 11.556

Review 9.  An Organotypic Microcosm for the Pancreatic Tumor Microenvironment.

Authors:  Miranda Lin; Mei Gao; Prakash K Pandalai; Michael J Cavnar; Joseph Kim
Journal:  Cancers (Basel)       Date:  2020-03-28       Impact factor: 6.639

10.  The Role of Tumor Microenvironment in Chemoresistance: 3D Extracellular Matrices as Accomplices.

Authors:  Dimakatso Alice Senthebane; Tina Jonker; Arielle Rowe; Nicholas Ekow Thomford; Daniella Munro; Collet Dandara; Ambroise Wonkam; Dhirendra Govender; Bridget Calder; Nelson C Soares; Jonathan M Blackburn; M Iqbal Parker; Kevin Dzobo
Journal:  Int J Mol Sci       Date:  2018-09-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.